Hepatitis B InfoCenter

THIS PAGE contains links to a variety of Hepatitis B information and news. This information is updated periodically. For easier navigation, this page has been subdivided into Publications, Papers, etc., and News Reports. All papers are copyright and permission for reproduction must be granted.

Publications, Papers and Websites

December 3, 2000: According to Toronto’s Sunday Star, ”Canada, concerned with health risks to its citizens and new demands on its already fragile Medicare system, plans to screen¬†would-be immigrants¬†for HIV and Hepatitis B and deny them entry if they test positive.

May 14, 2000: Find out more about hepatitis B, what it is, where it all began and more in¬†”Hepatitis B: The Complexities”, the first in a series of newsletters produced by Frank Anderson, M.D., FRCP(C) and his hepatitis team, Natalie Rock and Susan Campbell.

May 1, 2000: BioChem Pharma Inc. announced that new Zeffix data were presented today at the European Association for the Study of the Liver (EASL) congress, in Rotterdam.

April 2, 1999:¬†Dr. Christian Brechot, Professor Cell Biology/Hepatology, Paris, France, examines ”Specific Immunotherapy for the Control of Hepatitis B Virus Multiplication”

February 28, 1999: Learning that you have hepatitis B can be confusing and frightening. While medical science has made a lot of progress in learning about hepatitis, doctors still have many questions about it, and you probably do too. Take some time and go through this 12 part special patient section and hopefully many of your questions and concerns will be addressed.

November 15, 1998: Hepatitis B and C in the Chinese community is a very common problem. Dr. Florence Wong discusses the current issues and concerns

June 9, 1998: Dr. Morris Sherman, a Hepatologist practicing in Toronto, discusses current and future therapies for hepatitis B.

Interferon alpha is effective in the treatment of chronic hepatitis B in adults and is approved for this indication in the United States and several other countries. Its safety and efficacy has not been as carefully evaluated in children. This trial at several centers in Canada, Europe (Italy, German, Spain, Poland, Hungary, Romania, Lithuania, the Czech Republic) and the United States examined the use of interferon alpha in children between the ages of 1 and 17 years with chronic hepatitis B.

Hepatitis Vaccination: Questions and Answers

June 27, 1997 – Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children –¬†review by Dr. Howard Worman¬†and¬†The New England Journal abstract.

Most frequently asked questions to: Hepatologists, Gastroenterologists, Family Physicians, Nurses, and Public Health. These questions have been submitted with answers from all of these hepatitis specialists.


Sharing is caring!

Leave a Comment